Entrada Therapeutics Inc. (TRDA)
Market Closed
1 Sep, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
7. 08
+0.03
+0.4255%
After Hours
$
+0.56 +7.9096% 7. 64
273.69M Market Cap
- P/E Ratio
- Div Yield
16,162 Volume
-2.5 Eps
$ 7.05
Previous Close 
Want to track TRDA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Entrada Therapeutics Inc. (TRDA) Statistics
Valuation metrics
Market Cap 273.69M
Enterprise value 221.01M
Trailing P/E (ttm) -1.76
Forward P/E -
PEG ratio 0.03
Price/Sales (ttm) 57.99
Price/Book (mrq) 1.27
Enterprise Value/Revenue 47.16
Enterprise Value/EBITDA -1.34
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 111.6K
Average volume (90 days) 254.5K
Price summary
52-Week low 5.02
52-Week high 16.45
Beta -
50-Day moving average 7
200-Day moving average 11.31
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -35.38%
Operating margin -37.67%
Operational effectiveness
Return on assets -0.55%
Return on equity -0.58%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.11
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -3.93
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 5.28
Total debt (mrq) -
Total Debt/Equity (mrq) 0.21
Current ratio (mrq) 10.89%
Book value per share (mrq) 5.53
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
